The Hidden Link Between Endometriosis and Obesity: A State-of-the-Art Review
Translating that: a person weighing 100 kg might lose roughly 24 kg in that timeframe under favorable study conditions
The FDA-approved dosing schedule for semaglutide injection is once weekly , administered subcutaneously on the same day each week
Cardiovascular outcome trials have established benefits for specific agents: the LEADER trial for liraglutide, SUSTAIN-6 for injectable semaglutide, and REWIND for dulaglutide demonstrated reduced risk of major adverse cardiovascular events in patients with type 2 diabetes
9 These therapies include glucagon-like peptide-1 (GLP-1) receptor agonists, sodium-glucose cotransporter 2 (SGLT2) inhibitors, and biguanides, which promote weight loss, as well as dipeptidyl peptidase-4 inhibitors, alpha-glucosidase inhibitors, and bile-acid sequestrants, which are weight neutral
The exact mechanism is not fully understood and varies between individuals